Epidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent.
OBJECTIVE
To assess the prevalence of hirsutism and study its etiology in the Kashmir Valley of the Indian subcontinent.


METHODS
Prospective random sample of the general population attending outpatient medical clinics and prospective evaluation of hirsute patients referred to our endocrinology clinic.


METHODS
A tertiary care hospital and district-level primary care hospitals.


METHODS
Five thousand women attending various hospitals for reasons unrelated to hirsutism and 150 consecutive women referred for hirsutism.


METHODS
Assessment of body hair as per the Ferriman and Gallwey scoring system and an investigative protocol including detailed clinical assessment with endocrinologic workup including estimations of gonadotropins, PRL, T, and 17-hydroxyprogesterone and abdominopelvic ultrasound.


METHODS
Presence and cause of hirsutism.


RESULTS
Of 4,780 adult women for whom adequate data were available, 504 (10.5%) had hirsutism, among whom 484 (10.1%) had mild (score of 6-9) and 20 (0.4%) had moderate hirsutism (score of 10-14). The etiology of hirsutism revealed idiopathic hirsutism in 38.7%, polycystic ovary syndrome (PCOS) in 37.3%, postmenopausal state in 9.2%, adrenal tumors in 2.1%, congenital adrenal hyperplasia in 1.4%, and drug-induced hirsutism in 0.7%. The cause remained undetermined in 10.6% of patients for whom the available information was not adequate.


CONCLUSIONS
Hirsutism is as common a problem in the Kashmir Valley (India) as elsewhere in the world. Idiopathic hirsutism (38.7%), PCOS (37.3%), and postmenopausal state (9.2%) are common causes of hirsutism. Late-onset congenital adrenal hyperplasia is a relatively uncommon cause of hirsutism in the Kashmir Valley.
Zargar
Abdul Hamid
AH
Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India. abdulhamidz@vsnl.com
Wani
Arshad Iqbal
AI
Masoodi
Shariq Rashid
SR
Laway
Bashir Ahmad
BA
Bashir
Mir Iftikhar
MI
Salahuddin
Mohammad
M
D019326:17-alpha-Hydroxyprogesterone / Q000097:blood; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000150:complications; D000312:Adrenal Hyperplasia, Congenital / Q000150:complications; D000328:Adult; D000368:Aged; D005260:Female; D006628:Hirsutism / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology*; D006801:Humans; D007194:India / Q000453:epidemiology; D008875:Middle Aged; D011085:Polycystic Ovary Syndrome / Q000150:complications; D017698:Postmenopause; D011388:Prolactin / Q000097:blood; D013739:Testosterone / Q000097:blood
D013739:Testosterone; D019326:17-alpha-Hydroxyprogesterone; D011388:Prolactin